| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/22/2009 | EP1280900B1 Dendritic cell co-stimulatory molecules |
| 07/22/2009 | EP1246921B1 Increased lysine production by gene amplification using coryneform bacteria |
| 07/22/2009 | EP1235853B1 Multimeric forms of tnf superfamily ligands |
| 07/22/2009 | EP1220922B1 Method of identifying a compound with efficacy in the treatment of chronic inflammatory diseases |
| 07/22/2009 | EP1133517B1 INTRANUCLEAR TARGETED DELIVERY OF COMPOUNDS BY 70 kD HEAT SHOCK PROTEIN |
| 07/22/2009 | EP0954326B2 A process for viral inactivation of lyophilized blood proteins |
| 07/22/2009 | EP0873135B1 Peanut allergens and methods |
| 07/22/2009 | CN101490082A Method for producing insulin analogs having a dibasic B chain terminus |
| 07/22/2009 | CN101490081A Fusion peptide for inhibiting interaction of neuronal NMDA receptor (NMDAR) and NMDAR interacting proteins |
| 07/22/2009 | CN101490080A Pharmaceutical composition for alleviation and treatment of ischemic conditions and method for delivering the same |
| 07/22/2009 | CN101490079A Plant growth and stress tolerance related isozyme, encoding gene and use thereof |
| 07/22/2009 | CN101486766A Peptide-based immunization therapy for treatment of atherosclerosis and development of peptide-based assay for determination of immune responses against oxidized low density lipoprotein |
| 07/22/2009 | CN101486764A Technetium-99m marked 6-hydrazino pyridine-3-formamido novel lactose albumin complexes, preparation and use thereof |
| 07/22/2009 | CN101486763A Technetium-99m marked dimercapto propionamido novel lactose albumin complexes, preparation and use thereof |
| 07/22/2009 | CN101486762A Antibody, method and reagent kit for detecting and determining chlorogenic acid |
| 07/22/2009 | CN101486761A Human coagulation factor VII variants |
| 07/22/2009 | CN101486760A Recombinant protein capable of combining with vascular endothelial cell growth factor and placenta growth factor, as well as preparation method and application thereof |
| 07/22/2009 | CN101486759A Human Toll-like receptor protein, related reagent and method |
| 07/22/2009 | CN101486758A Mda-7/IL-24 mutant polypeptide, and preparation and use thereof |
| 07/22/2009 | CN101486757A Plant chloroplast development associated protein, and coding gene and use thereof |
| 07/22/2009 | CN101486756A Outer surface proteins, their genes, and their use |
| 07/22/2009 | CN100516224C Isozymes of lacrimator component synthase and gene encoding same |
| 07/22/2009 | CN100516221C Nucleotide sequences of mutant swine fever viral strin, polypeptides encoded by these squences and use thereof |
| 07/22/2009 | CN100516220C Serine proteinase inhibitor of bifidobacteria |
| 07/22/2009 | CN100516219C Malaria plasmodium antigen polypeptide SE36, method of purifying same and vaccine and diagnosis with use of obtained antigen |
| 07/22/2009 | CN100516215C Bovine lactation associated immunotropic protein (CD14), encoding gene and application in B cell activation |
| 07/22/2009 | CN100516081C Motoneuronotrophic factor gene sequences |
| 07/22/2009 | CN100516007C Process for preparing stereo arrested amine nitrogen oxygen free redical with hydrotalcite analog as catalyst |
| 07/22/2009 | CN100515494C Immunisation against chlamydia trachomatis |
| 07/22/2009 | CN100515492C Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, purpose thereof and method of making same |
| 07/21/2009 | US7563964 Inbred maize line PHEHC |
| 07/21/2009 | US7563949 Comprises nucleotide sequences and vectors coding genes associated with fatty acid biosynthesis for producing seeds with increased oleic acid and decreased linolenic acid; food processing; vegetable oils; desaturases |
| 07/21/2009 | US7563948 Sugar and lipid metabolism regulators in plants |
| 07/21/2009 | US7563947 Plant cells and plant bodies with modified cell growth, development and differentiation |
| 07/21/2009 | US7563946 Using cyclin dependent kinase sequences for modulating or mimicking auxin-related effects in a plant or plant cell; tissue engineering and plants |
| 07/21/2009 | US7563945 Plant regulatory sequences for selective control of gene expression |
| 07/21/2009 | US7563883 Recombinant P. falciparum merozoite protein-142 vaccine |
| 07/21/2009 | US7563882 Comprises polypeptide for diagnosis and treatment of tumors; immunotherapy |
| 07/21/2009 | US7563881 Nucleic acid encoding polypeptide involved in cellular entrance of the PRRS virus |
| 07/21/2009 | US7563880 Compositions and methods for the therapy and diagnosis of breast cancer |
| 07/21/2009 | US7563879 receptor-based gene expression modulation system for drug screening; genetic engineering |
| 07/21/2009 | US7563876 For binding and blocking human mannose receptors; fibronectins; immunoglobulins; cd antigens; cytolysis; cytotoxic lymphocytes; for treatment of automimmune diseases |
| 07/21/2009 | US7563872 Gene coding, gene expression, purification; used as detergents, cosmetics, leather processing, softening for food, meats, animal feeds |
| 07/21/2009 | US7563871 Polymer-based sustained release device |
| 07/21/2009 | US7563870 LAGE-1 tumor associated nucleic acids |
| 07/21/2009 | US7563869 Programmed Death 1(PD-1); bispecific antibodies comprising antibodies against human T cell receptor complex or human B cell receptor complex; autoimmune diseases |
| 07/21/2009 | US7563868 NRIF3, a novel co-activator for nuclear hormone receptors |
| 07/21/2009 | US7563867 PRO4356 polypeptides |
| 07/21/2009 | US7563866 Modular antigen transporter molecules (MAT molecules) for modulating immune reactions, associated constructs, methods and uses |
| 07/21/2009 | US7563864 Prolyl endopeptidase mediated destruction of T cell epitopes in whole gluten |
| 07/21/2009 | US7563863 Plastid transit peptides |
| 07/21/2009 | US7563862 Neural regeneration peptides and methods for their use in treatment of brain damage |
| 07/21/2009 | US7563776 First sequence of human low affinity nerve growth factor receptor or a polynucleotide coding for it and a second sequence of a mutant hiv nef gene or a polynucleotide coding for it |
| 07/21/2009 | US7563775 Insulin-responsive DNA binding protein-1 and methods to regulate insulin-responsive genes |
| 07/21/2009 | US7563771 Polypeptide with specific amino acid sequence enhances binding of low-density lipoprotein (LDL) or very low density lipoprotein (VLDL) to a cell, thus reducing the cholesterol and other cardiovascular disorders |
| 07/21/2009 | US7563769 Fibroblast growth factor (FGF); enhanced receptor subtype specificity and/or affinity; for treatment of skeletal dysplasia, osteoporosis and enhancing bone fracture healing and cartilage healing processes; mitogens |
| 07/21/2009 | US7563767 Functional genomics, bioinformatics |
| 07/21/2009 | US7563765 Histidine-rich glycoprotein |
| 07/21/2009 | US7563763 FSH and FSH variant formulations, products and methods |
| 07/21/2009 | US7563762 Composition and process for stabilizing of biomolecules |
| 07/21/2009 | US7563760 P-selectin ligand protein |
| 07/21/2009 | US7563596 Isolated cDNA encoding a growth-inducing protein, Frzb, capable of stimulating bone, cartilage, muscle and nerve tissue formation; binds to and modulates the activity of Wnt growth factors which play a role in various developmental and neoplastic processes |
| 07/21/2009 | US7563595 Comprises nucleotide coding nicotinic receptor for use in identifying modulators for treatment of enzymatic, affective, neurodegenerative and immunological diseases |
| 07/21/2009 | US7563594 Using primers applicable to multiplex PCR that simultaneously allows for the rapid and convenient determination of the presence of Campylobacter CDT and identification of species, and they can also be used in PCR-RFLP (restriction fragment length polymorphism) based typing |
| 07/21/2009 | US7563586 Tetrodotoxin resistant membrane protein for use in pain management |
| 07/21/2009 | US7563585 Drug screening for inhibitors of the IL-4 receptor-mediated signaling cascade involved in B-cell isotype switching to, and consequent production of, IgE; allergies, eczema, asthma |
| 07/21/2009 | US7563583 Having enhanced affinity for the ErbB-3 and ErbB-4 receptors; enhancing survival, proliferation, of differentiation cells |
| 07/21/2009 | US7563582 Identifying chemical compounds which are capable of modulating the interaction between vasodilator-stimulated phosphoprotein and zyxin |
| 07/21/2009 | US7563568 Using nucleic acid hybridization and visual analysis to identify translocations, aneuploidys, large insertions, large deletions, chromosome rearrangement/breaks along chromosome 12q15; diagnosing cancer, asthma and inflammatory disorders |
| 07/21/2009 | US7563450 UL16 binding protein 4 |
| 07/21/2009 | US7563448 Antitumor agents; enhanced by administration of cytoxic T lymphocyte (CTLA-4) blocker and/or cytosine-guanosine (CpG) oligodeoxynucleotide immunomodulators |
| 07/21/2009 | US7563445 Tumor antigens/vaccines such as cytotoxic T-lymphocytes (CTL) |
| 07/21/2009 | US7563444 Exhibits tissue specific expression in normal adult tissue, and is aberrantly expressed in the cancers; used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 213P1F11 can be used in active or passive immunization. |
| 07/21/2009 | US7563440 vaccination against malaria comprising epitopes contained within merozoite surface proteins (MSP) or polypeptides, and carriers such as alums and/or freund's adjuvants; inoculation; immunology |
| 07/21/2009 | US7563438 Antibodies to fibroblast growth factor; fusion proteins; cardiovascular disorders |
| 07/21/2009 | US7563278 Drug-eluting intravascular prostheses and methods of use |
| 07/21/2009 | CA2133834C Process for preparing modified proteins |
| 07/21/2009 | CA2104643C Serum free medium |
| 07/16/2009 | WO2009089461A1 Plexind1 agonists and their use |
| 07/16/2009 | WO2009089430A1 Solubilization and study of membrane proteins |
| 07/16/2009 | WO2009089121A2 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 07/16/2009 | WO2009088968A2 Engineered transglutaminase barrel proteins |
| 07/16/2009 | WO2009088949A1 Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| 07/16/2009 | WO2009088931A1 Method of selecting soybeans with enhanced bioactivity and compositions for reducing cancer cell viability |
| 07/16/2009 | WO2009088876A2 Transgenic non-human animals expressing human blood clotting factors |
| 07/16/2009 | WO2009088737A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/16/2009 | WO2009088732A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/16/2009 | WO2009088731A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/16/2009 | WO2009088730A1 Novel bacillus thuringiensis gene with coleopteran activity |
| 07/16/2009 | WO2009088713A1 Substantially animal protein-free recombinant furin and methods for producing same |
| 07/16/2009 | WO2009088405A2 System and method utilizing the expression of tlk1b protein in normal human cells to protect against dna damage |
| 07/16/2009 | WO2009088403A2 Nontoxic shiga-like toxin mutant compositions and methods |
| 07/16/2009 | WO2009088022A1 Novel cancer marker, and diagnosis using the same |
| 07/16/2009 | WO2009087508A1 Production of heterologous proteins or peptides |
| 07/16/2009 | WO2009087462A2 Ephrin type-a receptor 10 protein |
| 07/16/2009 | WO2009087424A2 Proteinaceous compounds |
| 07/16/2009 | WO2009087394A1 Cren7 chimeric protein |
| 07/16/2009 | WO2009087356A1 Host range change phage |
| 07/16/2009 | WO2009087110A1 Secretable hiv entry inhibitory peptides for therapy of hiv infection |
| 07/16/2009 | WO2009087082A2 Novel insulin derivatives having an extremely delayed time-action profile |